BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, León AR, Oshinski JN. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 2010;121:1985-91. [PMID: 20421518 DOI: 10.1161/CIRCULATIONAHA.109.910778] [Cited by in Crossref: 211] [Cited by in F6Publishing: 48] [Article Influence: 17.6] [Reference Citation Analysis]
Number Citing Articles
1 Szabó B, Marosi EK, Vargová K, Nyolczas N. Cardiac Index by Transthoracic Echocardiography (CITE) study. PLoS One 2018;13:e0207269. [PMID: 30540751 DOI: 10.1371/journal.pone.0207269] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Almusaad A, Sweidan R, Alanazi H, Jamiel A, Bokhari F, Al Hebaishi Y, Al Fagih A, Alrawahi N, Al-Mandalawi A, Hashim M, Al Ghamdi B, Amin M, Elmaghawry M, Al Shoaibi N, Sorgente A, Loricchio M, AlMohani G, Al Abri I, Benjamin E, Sudan N, Chami A, Badie N, Sayed M, Hersi A. Long-term reverse remodeling and clinical improvement by MultiPoint Pacing in a randomized, international, Middle Eastern heart failure study. J Interv Card Electrophysiol 2021. [PMID: 34156610 DOI: 10.1007/s10840-020-00928-2] [Reference Citation Analysis]
3 Leyva F. Cardiac resynchronization therapy guided by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:64. [PMID: 21062491 DOI: 10.1186/1532-429X-12-64] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
4 Wilton SB, Exner DV, Wyse DG, Yetisir E, Wells G, Tang AS, Healey JS. Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial. Circ Arrhythm Electrophysiol 2016;9. [DOI: 10.1161/circep.115.003807] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Sorgente A, Cappato R. A Critical Reappraisal of the Current Clinical Indications to Cardiac Resynchronisation Therapy. Arrhythm Electrophysiol Rev 2013;2:91-4. [PMID: 26835046 DOI: 10.15420/aer.2013.2.2.91] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Thibault B, Harel F, Ducharme A, White M, Ellenbogen KA, Frasure-smith N, Roy D, Philippon F, Dorian P, Talajic M, Dubuc M, Guerra PG, Macle L, Rivard L, Andrade J, Khairy P. Cardiac Resynchronization Therapy in Patients With Heart Failure and a QRS Complex <120 Milliseconds: The Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) Trial. Circulation 2013;127:873-81. [DOI: 10.1161/circulationaha.112.001239] [Cited by in Crossref: 91] [Cited by in F6Publishing: 25] [Article Influence: 10.1] [Reference Citation Analysis]
7 Upadhyay GA, Vijayaraman P. How to Choose Between His Bundle Pacing and Biventricular Pacing for Cardiac Resynchronization Therapy. Curr Cardiovasc Risk Rep 2019;13. [DOI: 10.1007/s12170-019-0598-9] [Reference Citation Analysis]
8 Bazoukis G, Thomopoulos C, Tse G, Tsioufis K, Nihoyannopoulos P. Global longitudinal strain predicts responders after cardiac resynchronization therapy-a systematic review and meta-analysis. Heart Fail Rev 2021. [PMID: 33782788 DOI: 10.1007/s10741-021-10094-w] [Reference Citation Analysis]
9 Borgquist R, Barrington WR, Bakos Z, Werther-evaldsson A, Saba S. Targeting the latest site of left ventricular mechanical activation is associated with improved long-term outcomes for recipients of Cardiac Resynchronization Therapy. Heart Rhythm O2 2022. [DOI: 10.1016/j.hroo.2022.05.003] [Reference Citation Analysis]
10 Bai RJ, Ren SH, Jiang HJ, Li JP, Liu XC, Xue LM. Accuracy of Multi-Slice Spiral Computed Tomography for Preoperative Tumor Node Metastasis (TNM) Staging of Colorectal Carcinoma. Med Sci Monit 2017;23:3470-9. [PMID: 28715364 DOI: 10.12659/msm.902649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Proclemer A, Muser D, Facchin D. What We Can Learn from "Super-responders". Card Electrophysiol Clin 2015;7:781-8. [PMID: 26596819 DOI: 10.1016/j.ccep.2015.08.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Lahiri A, Chahadi FK, Ganesan AN, Mcgavigan AD. Characteristics that Predict Response After Cardiac Resynchronization Therapy. Curr Cardiovasc Risk Rep 2020;14. [DOI: 10.1007/s12170-020-00640-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 McAloon CJ, Barwari T, Hu J, Hamborg T, Nevill A, Hyndman S, Ansell V, Musa A, Jones J, Goodby J, Banerjee P, O'Hare P, Mayr M, Randeva H, Osman F. Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study. Open Heart 2018;5:e000899. [PMID: 30364565 DOI: 10.1136/openhrt-2018-000899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
14 Yang N, Liang ZG, Wang ZJ, Liu H, Chi C, Tian YF, Qi SH, Wang BY, Han W. Combined myocardial deformation to predict cardiac resynchronization therapy response in nonischemic cardiomyopathy. Pacing Clin Electrophysiol 2017;40:986-94. [PMID: 28691201 DOI: 10.1111/pace.13151] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Dickstein K. Response to Coceani: Cardiac resynchronization therapy has earned its class I recommendation and continues to thrive under scrutiny. Circ Heart Fail 2010;3:556-8. [PMID: 20647491 DOI: 10.1161/CIRCHEARTFAILURE.110.957613] [Reference Citation Analysis]
16 O'Donnell D, Manyam H, Pappone C, Park SJ, Leclercq C, Lunati M, Lercher P, Rordorf R, Landolina M, Badie N, McSpadden LC, Ryu K, Mangual JO, Singh JP, Varma N, Niazi IK. Ventricular activation patterns during intrinsic conduction and right ventricular pacing in cardiac resynchronization therapy patients. Pacing Clin Electrophysiol 2021;44:1663-70. [PMID: 34319603 DOI: 10.1111/pace.14329] [Reference Citation Analysis]
17 McAloon CJ, Theodoreson MD, Hayat S, Osman F. Cardiac resynchronization therapy and its role in the management of heart failure. Br J Hosp Med (Lond) 2017;78:312-9. [PMID: 28614025 DOI: 10.12968/hmed.2017.78.6.312] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Roubicek T, Stros J, Kucera P, Nedbal P, Cerny J, Polasek R, Wichterle D. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome. PLoS One 2019;14:e0219966. [PMID: 31314790 DOI: 10.1371/journal.pone.0219966] [Reference Citation Analysis]
19 Forleo GB, Santini L, Giammaria M, Potenza D, Curnis A, Calabrese V, Ricciardi D, D'agostino C, Notarstefano P, Ribatti V, Morani G, Mantica M, Di Biase L, Bertaglia E, Calò L, Zanon F. Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP). Europace 2017;19:1170-7. [PMID: 27189954 DOI: 10.1093/europace/euw094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
20 Poulidakis E, Aggeli C, Sideris S, Sfendouraki E, Koutagiar I, Katsaros A, Giannoulis E, Koukos M, Margioula E, Lagoudakou S, Gatzoulis K, Dilaveris P, Kallikazaros I, Couloheri S, Stefanadis C, Tousoulis D. Echocardiography for prediction of 6-month and late response to cardiac resynchronization therapy: implementation of stress echocardiography and comparative assessment along with widely used dyssynchrony indices. Int J Cardiovasc Imaging 2019;35:285-94. [PMID: 30623352 DOI: 10.1007/s10554-018-01520-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
21 Brugada J, Brachmann J, Delnoy PP, Padeletti L, Reynolds D, Ritter P, Borri-Brunetto A, Singh JP. Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND CRT) trial. Am Heart J 2014;167:429-36. [PMID: 24655689 DOI: 10.1016/j.ahj.2013.12.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
22 Hage FG. Left ventricular mechanical dyssynchrony by phase analysis as a prognostic indicator in heart failure. J Nucl Cardiol 2014;21:67-70. [PMID: 24272972 DOI: 10.1007/s12350-013-9822-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Yin Y, Dimopoulos K, Shimada E, Lascelles K, Griffiths S, Wong T, Gatzoulis MA, Babu-Narayan SV, Li W. Early and Late Effects of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease. J Am Heart Assoc 2019;8:e012744. [PMID: 31657270 DOI: 10.1161/JAHA.119.012744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bakos Z, Chatterjee NC, Reitan C, Singh JP, Borgquist R. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score. BMC Cardiovasc Disord 2018;18:70. [PMID: 29699498 DOI: 10.1186/s12872-018-0802-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
25 Uhm JS, Oh J, Cho IJ, Park M, Kim IS, Jin MN, Bae HJ, Yu HT, Kim TH, Pak HN, Lee MH, Joung B, Kang SM. Left Ventricular End-Systolic Volume Can Predict 1-Year Hierarchical Clinical Composite End Point in Patients with Cardiac Resynchronization Therapy. Yonsei Med J 2019;60:48-55. [PMID: 30554490 DOI: 10.3349/ymj.2019.60.1.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
26 Ajaero CN, Chong CR, Procter NEK, Liu S, Chirkov YY, Heresztyn T, Chan WPA, Arstall MA, McGavigan AD, Frenneaux MP, Horowitz JD. Does cardiac resynchronization therapy restore peripheral circulatory homeostasis? ESC Heart Fail 2018;5:129-38. [PMID: 29030923 DOI: 10.1002/ehf2.12211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Sundaram V, Sahadevan J, Waldo AL, Stukenborg GJ, Reddy YNV, Asirvatham SJ, Mackall JA, Intini A, Wilson B, Simon DI, Bilchick KC. Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms. J Am Coll Cardiol 2017;69:2026-36. [PMID: 28427578 DOI: 10.1016/j.jacc.2017.02.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
28 Naqvi SY, Jawaid A, Goldenberg I, Kutyifa V. Non-response to Cardiac Resynchronization Therapy. Curr Heart Fail Rep 2018;15:315-21. [PMID: 30097910 DOI: 10.1007/s11897-018-0407-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
29 Butter C. [Cardiac resynchronisation therapy : new data and technical developments]. Herz 2011;36:577-85. [PMID: 21912913 DOI: 10.1007/s00059-011-3506-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Cai C, Hua W, Ding LG, Wang J, Chen KP, Yang XW, Liu ZM, Zhang S. High sensitivity C-reactive protein and cardfiac resynchronization therapy in patients with advanced heart failure. J Geriatr Cardiol 2014;11:296-302. [PMID: 25593578 DOI: 10.11909/j.issn.1671-5411.2014.04.004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
31 Schmitz B, De Maria R, Gatsios D, Chrysanthakopoulou T, Landolina M, Gasparini M, Campolo J, Parolini M, Sanzo A, Galimberti P, Bianchi M, Lenders M, Brand E, Parodi O, Lunati M, Brand S. Identification of Genetic Markers for Treatment Success in Heart Failure Patients: Insight From Cardiac Resynchronization Therapy. Circ Cardiovasc Genet 2014;7:760-70. [DOI: 10.1161/circgenetics.113.000384] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
32 Machino T, Sato A, Murakoshi N, Ieda M. Phase I investigator-initiated study of the safety of MTC001 in patients with chronic ischemic heart failure. Medicine (Baltimore) 2021;100:e28372. [PMID: 34941159 DOI: 10.1097/MD.0000000000028372] [Reference Citation Analysis]
33 Varma N, Sogaard P, Bax JJ, Abraham WT, Borer JS, Dickstein K, Singh JP, Gras D, Holzmeister J, Brugada J, Ruschitzka F. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial. J Am Heart Assoc 2018;7:e009592. [PMID: 29807890 DOI: 10.1161/JAHA.118.009592] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
34 Perge P, Boros AM, Zima E, Gellér L, Merkely B, Széplaki G. Hyperuricemia predicts adverse clinical outcomes after cardiac resynchronization therapy. Scand Cardiovasc J 2018;52:250-5. [PMID: 30714413 DOI: 10.1080/14017431.2018.1499954] [Reference Citation Analysis]
35 Butcher C, Mareev Y, Markides V, Mason M, Wong T, Cleland JG. Cardiac resynchronization therapy update: evolving indications, expanding benefit? Curr Cardiol Rep 2015;17:90. [PMID: 26298308 DOI: 10.1007/s11886-015-0641-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Jessup M. Defining success in heart failure: the end-point mess. Circulation 2010;121:1977-80. [PMID: 20421517 DOI: 10.1161/CIRCULATIONAHA.110.946988] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
37 Chung ES, Gold MR, Abraham WT, Young JB, Linde C, Anderson C, Lu X, Ikuemonisan JO, Fagan DH, Tsintzos SI, Rickard J. The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies. Heart Rhythm 2021:S1547-5271(21)02420-6. [PMID: 34843964 DOI: 10.1016/j.hrthm.2021.11.030] [Reference Citation Analysis]
38 Neuss M, Butter C. [Role of imaging in cardiac resynchronization therapy]. Herzschrittmacherther Elektrophysiol 2011;22:4-10. [PMID: 21344234 DOI: 10.1007/s00399-011-0116-3] [Reference Citation Analysis]
39 Liu J, Adelstein E, Saba S. Targeting left ventricular lead placement to improve cardiac resynchronization therapy outcomes. Curr Cardiol Rep 2013;15:390. [PMID: 23812839 DOI: 10.1007/s11886-013-0390-2] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
40 Leclercq C, Burri H, Curnis A, Delnoy PP, Rinaldi CA, Sperzel J, Lee K, Cohorn C, Thibault B; MORE-CRT MPP Investigators. Rationale and design of a randomized clinical trial to assess the safety and efficacy of multipoint pacing therapy: MOre REsponse on Cardiac Resynchronization Therapy with MultiPoint Pacing (MORE-CRT MPP-PHASE II). Am Heart J 2019;209:1-8. [PMID: 30616009 DOI: 10.1016/j.ahj.2018.12.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
41 Nakai T, Ikeya Y, Mano H, Kogawa R, Watanabe R, Arai M, Aizawa Y, Kurokawa S, Ohkubo K, Kitano D, Nagashima K, Okumura Y, Maekawa Y. Efficacy of Cardiac Resynchronization Therapy in Patients with a Narrow QRS Complex. Journal of Interventional Cardiology 2021;2021:1-7. [DOI: 10.1155/2021/8858836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Zhu H, Zou T, Zhong Y, Yang C, Ren Y, Wang F. Prevention of non-response to cardiac resynchronization therapy: points to remember. Heart Fail Rev 2020;25:269-75. [PMID: 31352624 DOI: 10.1007/s10741-019-09834-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
43 Tung R, Upadhyay GA. Defining Left Bundle Branch Block Patterns in Cardiac Resynchronisation Therapy: A Return to His Bundle Recordings. Arrhythm Electrophysiol Rev 2020;9:28-33. [PMID: 32637117 DOI: 10.15420/aer.2019.12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Verschure DO, Poel E, De Vincentis G, Frantellizzi V, Nakajima K, Gheysens O, de Groot JR, Verberne HJ. The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation. Eur Heart J Cardiovasc Imaging 2021;22:49-57. [PMID: 32259839 DOI: 10.1093/ehjci/jeaa045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Nakai T, Ikeya Y, Kogawa R, Otsuka N, Wakamatsu Y, Kurokawa S, Ohkubo K, Nagashima K, Okumura Y. What Are the Expectations for Cardiac Resynchronization Therapy? A Validation of Two Response Definitions. J Clin Med 2021;10:514. [PMID: 33535633 DOI: 10.3390/jcm10030514] [Reference Citation Analysis]
46 Almeida-Morais L, Abreu A, Oliveira M, Silva Cunha P, Rodrigues I, Portugal G, Rio P, Soares R, Mota Carmo M, Cruz Ferreira R. Impact of cardiac resynchronization therapy on inflammatory biomarkers and cardiac remodeling: The paradox of functional and echocardiographic response. Rev Port Cardiol (Engl Ed) 2018;37:105-13. [PMID: 29503051 DOI: 10.1016/j.repc.2017.06.017] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
47 Buga L. How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection? Heart Fail Rev 2012;17:791-802. [PMID: 23054220 DOI: 10.1007/s10741-012-9351-x] [Reference Citation Analysis]
48 Raj A, Nath RK, Pandit BN, Singh AP, Pandit N, Aggarwal P. Comparing the Modified Frailty Index with conventional scores for prediction of cardiac resynchronization therapy response in patients with heart failure. J Frailty Sarcopenia Falls 2021;6:79-85. [PMID: 34131604 DOI: 10.22540/JFSF-06-079] [Reference Citation Analysis]
49 Packer M. Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective. Circulation 2016;134:1664-78. [PMID: 27881506 DOI: 10.1161/CIRCULATIONAHA.116.023538] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
50 Okafor O, Zegard A, van Dam P, Stegemann B, Qiu T, Marshall H, Leyva F. Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias. J Am Heart Assoc 2019;8:e013539. [PMID: 31657269 DOI: 10.1161/JAHA.119.013539] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
51 Hartlage GR, Suever JD, Clement-Guinaudeau S, Strickland PT, Ghasemzadeh N, Magrath RP 3rd, Parikh A, Lerakis S, Hoskins MH, Leon AR, Lloyd MS, Oshinski JN. Prediction of response to cardiac resynchronization therapy using left ventricular pacing lead position and cardiovascular magnetic resonance derived wall motion patterns: a prospective cohort study. J Cardiovasc Magn Reson 2015;17:57. [PMID: 26170046 DOI: 10.1186/s12968-015-0158-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
52 The Editors. Circulation Editors' Picks: Most Read Articles in Arrhythmia and Electrophysiology, Part I. Circulation 2011;124. [DOI: 10.1161/circulationaha.111.056416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Auger D, Delgado V, Bax JJ. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy. American Heart Journal 2011;161:e23. [DOI: 10.1016/j.ahj.2011.01.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Cha Y, Chareonthaitawee P, Dong Y, Kemp BJ, Oh JK, Miyazaki C, Hayes DL, Rea RF, Asirvatham SJ, Webster TL, Dalzell CM, Hodge DO, Herges RM, Yong Y, Zhang Y, Chen P. Cardiac Sympathetic Reserve and Response to Cardiac Resynchronization Therapy. Circ Heart Fail 2011;4:339-44. [DOI: 10.1161/circheartfailure.110.959858] [Cited by in Crossref: 42] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
55 Gamble JH, Betts TR. Multisite left ventricular pacing in cardiac resynchronization therapy. Future Cardiol 2014;10:469-77. [PMID: 25301310 DOI: 10.2217/fca.14.31] [Reference Citation Analysis]
56 Sultan A, Wörmann J, Lüker J, V D Bruck J-, Plenge T, Rudolph V, Klinke A, Heijman J, Mollenhauer M, Ravekes T, Baldus S, Steven D. Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response. Clin Res Cardiol 2021;110:1173-80. [PMID: 32564144 DOI: 10.1007/s00392-020-01690-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Ciconte G, Ćalović Ž, Vicedomini G, Cuko A, McSpadden LC, Jiang C, Ryu K, Caporaso I, Stutz R, Winter D, Saviano M, Vitale R, Conti M, Santinelli V, Pappone C. Multipoint pacing improves peripheral hemodynamic response: Noninvasive assessment using radial artery tonometry. Pacing Clin Electrophysiol 2018;41:106-13. [PMID: 29222865 DOI: 10.1111/pace.13254] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
58 Leenders GE, Cramer MJ, Bogaard MD, Meine M, Doevendans PA, De Boeck BW. Echocardiographic prediction of outcome after cardiac resynchronization therapy: conventional methods and recent developments. Heart Fail Rev 2011;16:235-50. [PMID: 21104122 DOI: 10.1007/s10741-010-9200-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
59 Padeletti L, Paoletti Perini A, Gronda E. Cardiac resynchronization therapy: the issue of non-response. Heart Fail Rev 2012;17:97-105. [PMID: 21533977 DOI: 10.1007/s10741-011-9250-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
60 Khan SG, Klettas D, Kapetanakis S, Monaghan MJ. Clinical utility of speckle-tracking echocardiography in cardiac resynchronisation therapy. Echo Res Pract 2016;3:R1-R11. [PMID: 27249816 DOI: 10.1530/ERP-15-0032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
61 Xie M, Burchfield JS, Hill JA. Pathological ventricular remodeling: therapies: part 2 of 2. Circulation 2013;128:1021-30. [PMID: 23979628 DOI: 10.1161/CIRCULATIONAHA.113.001879] [Cited by in Crossref: 90] [Cited by in F6Publishing: 54] [Article Influence: 10.0] [Reference Citation Analysis]
62 Pappone C, alovi, Cuko A, Mcspadden LC, Ryu K, Jordan CD, Saviano M, Baldi M, Pappone A, Dozza L, Giannelli L, Fragakis N, Vicedomini G, Santinelli V. Multipoint left ventricular pacing provides additional echocardiographic benefit to responders and non-responders to conventional cardiac resynchronization therapy. European Heart Journal Supplements 2015;17:A12-7. [DOI: 10.1093/eurheartj/suv005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Thibault B, Ducharme A, Harel F, White M, O'meara E, Guertin M, Lavoie J, Frasure-smith N, Dubuc M, Guerra P, Macle L, Rivard L, Roy D, Talajic M, Khairy P; for the Evaluation of Resynchronization Therapy for Heart Failure (GREATER-EARTH) Investigators. Left Ventricular Versus Simultaneous Biventricular Pacing in Patients With Heart Failure and a QRS Complex ≥120 Milliseconds. Circulation 2011;124:2874-81. [DOI: 10.1161/circulationaha.111.032904] [Cited by in Crossref: 97] [Cited by in F6Publishing: 22] [Article Influence: 8.8] [Reference Citation Analysis]
64 Varma N, Bourge RC, Stevenson LW, Costanzo MR, Shavelle D, Adamson PB, Ginn G, Henderson J, Abraham WT; CHAMPION Investigator Group. Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy. J Am Heart Assoc 2021;10:e017619. [PMID: 33626889 DOI: 10.1161/JAHA.120.017619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
65 Liu W, Hu C, Wang Y, Cheng Y, Zhao Y, Liu Y, Zheng S, Chen H, Shu X. Mechanical Synchrony and Myocardial Work in Heart Failure Patients With Left Bundle Branch Area Pacing and Comparison With Biventricular Pacing. Front Cardiovasc Med 2021;8:727611. [PMID: 34490382 DOI: 10.3389/fcvm.2021.727611] [Reference Citation Analysis]
66 Massoullié G, Sapin V, Ploux S, Rossignol P, Mulliez A, Jean F, Marie PY, Merlin C, Pereira B, Andronache M, Motreff P, Chabin X, Sellal JM, Citron B, Lusson JR, Vorilhon C, Clerfond G, Bordachar P, Zannad F, Eschalier R. Low fibrosis biomarker levels predict cardiac resynchronization therapy response. Sci Rep 2019;9:6103. [PMID: 30988339 DOI: 10.1038/s41598-019-42468-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Naegeli B, Brunner-La Rocca HP, Attenhofer Jost C, Fah-Gunz A, Maurer D, Bertel O, Scharf C. Clinical Long-Term Response to Cardiac Resynchronization Therapy Is Independent of Persisting Echocardiographic Markers of Dyssynchrony. Cardiol Res 2014;5:163-70. [PMID: 28352448 DOI: 10.14740/cr368w] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Sieniewicz BJ, Gould J, Porter B, Sidhu BS, Teall T, Webb J, Carr-White G, Rinaldi CA. Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions. Heart Fail Rev 2019;24:41-54. [PMID: 30143910 DOI: 10.1007/s10741-018-9734-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
69 Miller EO, Malhotra S, Schwartz RG. Quantitative Radionuclide Assessment of Cardiac Dyssynchrony: Breakthrough in Patient Selection for Cardiac Resynchronization Therapy for Refractory Heart Failure? J Nucl Med 2016;57:1840-2. [PMID: 27754903 DOI: 10.2967/jnumed.116.177113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Tada T, Osuda K, Nakata T, Muranaka I, Himeno M, Muratsubaki S, Murase H, Sato K, Hirose M, Fukuma T. A novel approach to the selection of an appropriate pacing position for optimal cardiac resynchronization therapy using CT coronary venography and myocardial perfusion imaging: FIVE STaR method (fusion image using CT coronary venography and perfusion SPECT applied for cardiac resynchronization therapy). J Nucl Cardiol 2021;28:1438-45. [PMID: 31435883 DOI: 10.1007/s12350-019-01856-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
71 Kato H, Shimano M, Sumi T, Murakami H, Kada K, Inden Y, Tsuboi N, Murohara T. Acute improvement of left ventricular relaxation as a predictor of volume reduction after cardiac resynchronization therapy: a pilot study assessing the value of left ventricular hemodynamic parameter. Pacing Clin Electrophysiol 2014;37:1544-52. [PMID: 25113752 DOI: 10.1111/pace.12478] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Auger D, van Bommel RJ, Bertini M, Delgado V, Ng AC, Ewe SH, Shanks M, Marsan NA, Mooyaart EA, Witkowski T, Poldermans D, Schalij MJ, Bax JJ. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy. Am Heart J 2010;160:737-43. [PMID: 20934569 DOI: 10.1016/j.ahj.2010.07.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
73 Leitz P, Köbe J, Rath B, Reinke F, Frommeyer G, Andresen C, Güner F, Wolfes J, Lange PS, Ellermann C, Eckardt L, Dechering DG. Very Long-Term Follow-Up in Cardiac Resynchronization Therapy: Wider Paced QRS Equals Worse Prognosis. J Pers Med 2021;11:1176. [PMID: 34834528 DOI: 10.3390/jpm11111176] [Reference Citation Analysis]
74 Fyenbo DB, Sommer A, Nørgaard BL, Kronborg MB, Kristensen J, Gerdes C, Jensen HK, Jensen JM, Nielsen JC. Long-term outcomes in a randomized controlled trial of multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy. Europace 2022:euab314. [PMID: 35041000 DOI: 10.1093/europace/euab314] [Reference Citation Analysis]
75 Klein HU. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients. Curr Treat Options Cardiovasc Med 2010;12:431-42. [PMID: 20842565 DOI: 10.1007/s11936-010-0089-2] [Reference Citation Analysis]
76 Marek J, Gandalovičová J, Kejřová E, Pšenička M, Linhart A, Paleček T. Echocardiography and cardiac resynchronization therapy. Cor Vasa 2016;58:e340-51. [DOI: 10.1016/j.crvasa.2015.08.001] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
77 Pan W, Su Y, Zhu W, Shu X, Ge J. Notched QRS complex in lateral leads as a novel predictor of response to cardiac resynchronization therapy. Ann Noninvasive Electrocardiol 2013;18:181-7. [PMID: 23530489 DOI: 10.1111/anec.12008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
78 Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J, Sherfesee L, Wells GA, Tang AS. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013;34:3547-3556. [PMID: 23900696 DOI: 10.1093/eurheartj/eht290] [Cited by in Crossref: 278] [Cited by in F6Publishing: 214] [Article Influence: 30.9] [Reference Citation Analysis]
79 Yufu K, Kondo H, Shinohara T, Ishii Y, Yoshimura S, Abe I, Saito S, Fukui A, Okada N, Akioka H, Teshima Y, Nakagawa M, Takahashi N. Assessment of coronary flow reserve predicts long-term outcome of responders to cardiac resynchronization therapy. Heart Vessels 2019;34:763-70. [PMID: 30483876 DOI: 10.1007/s00380-018-1308-0] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
80 Chung ES, Rickard J, Lu X, DerSarkissian M, Zichlin ML, Cheung HC, Swartz N, Greatsinger A, Duh MS. Real-World Economic Burden Among Patients With And Without Heart Failure Worsening After Cardiac Resynchronization Therapy. Adv Ther 2021;38:441-67. [PMID: 33141415 DOI: 10.1007/s12325-020-01536-2] [Reference Citation Analysis]
81 Yuan H, Fan XS, Jin Y, He JX, Gui Y, Song LY, Song Y, Sun Q, Chen W. Development of heart failure risk prediction models based on a multi-marker approach using random forest algorithms. Chin Med J (Engl) 2019;132:819-26. [PMID: 30829708 DOI: 10.1097/CM9.0000000000000149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
82 McAloon CJ, Ali D, Hamborg T, Banerjee P, O'Hare P, Randeva H, Osman F. Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review. Open Heart 2017;4:e000639. [PMID: 28878953 DOI: 10.1136/openhrt-2017-000639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
83 Raj A, Singh AP, Nath RK, Pandit N, Aggarwal P, Thakur AK, Bharadwaj R, Kumar V. Six months clinical outcome comparison between quadripolar and bipolar left ventricular leads in cardiac resynchronization therapy: A prospective, non-randomized, single-centre observational study. Indian Pacing Electrophysiol J 2021;21:162-8. [PMID: 33636279 DOI: 10.1016/j.ipej.2021.02.009] [Reference Citation Analysis]
84 Drucker MN, Manyam H, Singh G, Glascock DN, Gillett S, Miller C, Sharmin K, Parks KA. MultiPole pacing in non-responders to cardiac resynchronization therapy: Results from the QP ExCELs/MPP sub-study. Pacing Clin Electrophysiol 2021;44:1683-90. [PMID: 34405423 DOI: 10.1111/pace.14339] [Reference Citation Analysis]
85 Alpendurada F, Guha K, Sharma R, Ismail TF, Clifford A, Banya W, Mohiaddin RH, Pennell DJ, Cowie MR, McDonagh T, Prasad SK. Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy. J Cardiovasc Magn Reson 2011;13:68. [PMID: 22040270 DOI: 10.1186/1532-429X-13-68] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
86 Menezes Junior ADS, Lopes CC, Cavalcante PF, Martins E. Chronic Chagas Cardiomyopathy Patients and Resynchronization Therapy: a Survival Analysis. Braz J Cardiovasc Surg 2018;33:82-8. [PMID: 29617506 DOI: 10.21470/1678-9741-2017-0134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
87 Varma N, Baker J, Tomassoni G, Love CJ, Martin D, Sheppard R, Niazi I, Cranke G, Lee K, Corbisiero R. Left Ventricular Enlargement, Cardiac Resynchronization Therapy Efficacy, and Impact of MultiPoint Pacing. Circ: Arrhythmia and Electrophysiology 2020;13. [DOI: 10.1161/circep.120.008680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
88 Toner L, Flannery D, Sugumar H, Ord M, Lin T, O'Donnell D. Electrical remodelling and response following cardiac resynchronization therapy: A novel analysis of intracardiac electrogram using a quadripolar lead. J Arrhythm 2018;34:274-80. [PMID: 29951143 DOI: 10.1002/joa3.12063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Kusiak A, Wiliński J, Wojciechowska W, Jastrzębski M, Sondej T, Kloch-Badełek M, Czarnecka DM. Echocardiographic assessment of right ventricular function in responders and non-responders to cardiac resynchronization therapy. Arch Med Sci 2015;11:736-42. [PMID: 26322084 DOI: 10.5114/aoms.2015.53292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]